ZYME Q1 2025 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+170.3% YoY

Gross Profit

$27M100.0% margin

Operating Income

-$26M-94.5% margin

Net Income

-$23M-83.5% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

-12.6%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$426M

Total Liabilities

$101M

Stockholders' Equity

$325M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$10M	+170.3%
Gross Profit	$27M	$10M	+170.3%
Operating Income	-$26M	-$38M	+32.2%
Net Income	-$23M	-$32M	+28.5%

Revenue Segments

Milestone Revenue

$14M75%

Research Support Payments And Other Service

$4M24%

Royalty

$202,0001%